During the past decade, Uni Di Cagliari; Dept. Di Scienze Mediche conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Uni Di Cagliari; Dept. Di Scienze Mediche" are "Hepatitis B, Chronic" (3 trials). Many other conditions were trialed in "Uni Di Cagliari; Dept. Di Scienze Mediche" in a lesser frequency.

Most popular intervention types in "Uni Di Cagliari; Dept. Di Scienze Mediche" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Interleukin 28B testing" (1 trials), "Nucleos(t)ide Analogues (NA)" (1 trials), "Peg-IFN alfa-2a" (1 trials) and "Pegylated Interferon (Peginterferon) Alfa-2a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uni Di Cagliari; Dept. Di Scienze Mediche" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Uni Di Cagliari; Dept. Di Scienze Mediche". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Uni Di Cagliari; Dept. Di Scienze Mediche, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uni Di Cagliari; Dept. Di Scienze Mediche, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".